Nuclear factor-κB activation by reactive oxygen species mediates voltage-gated K+ current enhancement by neurotoxic β-amyloid peptides in nerve growth factor-differentiated PC-12 cells and hippocampal neurones

Journal of Neurochemistry

Volumn 94, Issue 3, 2005, Pages 572-586

  Pannaccione, Anna ^a   Secondo, Agnese ^a   Scorziello, Antonella ^a   Calì, Gaetano ^a   Taglialatela, Maurizio ^a   Annunziato, Lucio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Alzheimer's disease; Intracellular Ca2+ concentration; Neuronal cell death; Nuclear factor B; Reactive oxygen species; Voltage gated K + channels

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; CALCIUM; CYCLOHEXIMIDE; DACTINOMYCIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NERVE GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; SN 50; SN 50M; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; 4 AMINOPYRIDINE; BDS I ANTIVIRAL PROTEIN, ANEMONIA SULCATA; BDS-I ANTIVIRAL PROTEIN, ANEMONIA SULCATA; CHARYBDOTOXIN; CHELATING AGENT; COELENTERATE VENOM; EGTAZIC ACID; ENZYME INHIBITOR; NEUROMODULIN; PEPTIDE; PEPTIDE FRAGMENT; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN SYNTHESIS INHIBITOR; RETINOL; TETRYLAMMONIUM;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL NUCLEUS; CELL STRAIN; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; HIPPOCAMPUS; INCUBATION TIME; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; TRANSCRIPTION INITIATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL MEMBRANE POTENTIAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; ELECTROSTIMULATION; EMBRYO; ENZYME ACTIVATION; METABOLISM; METHODOLOGY; MICROFILAMENT; NERVE CELL; PATCH CLAMP; PHYSIOLOGY; RADIATION EXPOSURE; TIME;

4-AMINOPYRIDINE; AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; CHARYBDOTOXIN; CHELATING AGENTS; CNIDARIAN VENOMS; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EGTAZIC ACID; ELECTRIC STIMULATION; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITORS; GAP-43 PROTEIN; HIPPOCAMPUS; MEMBRANE POTENTIALS; MICROFILAMENTS; NERVE GROWTH FACTOR; NEURONS; NF-KAPPA B; PATCH-CLAMP TECHNIQUES; PC12 CELLS; PEPTIDE FRAGMENTS; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN SYNTHESIS INHIBITORS; RATS; REACTIVE OXYGEN SPECIES; TETRAETHYLAMMONIUM; TIME FACTORS; VITAMIN A;

EID: 23244453593     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03075.x     Document Type: Article

References (65)

1. Abbott G. W., Butler M. H., Bendahhou S., Dalakas M. C., Ptacek L. J. and Goldstein S. A. (2001) MiRP2 forms potassium channels in skeletal muscle with Ku3.4 and is associated with periodic paralysis. Cell 104, 217-231.
2. Aleyasin H., Cregan S. P., Iyirhiaro G., O'Hare M. J., Callaghan S. M., Slack R. S. and Park D. S. (2004) Nuclear factor-(kappa) B modulates the p53 response in neurons exposed to DNA damage. J. Neurosci. 24, 2963-2973.
3. Angulo E., Noe V., Casado V., Mallol J., Gomez-Isla T., Lluis C., Ferrer I., Ciudad C. J. and Franco R. (2004) Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. J. Neurochem. 91, 547-557.
4. Annunziato L., Pannaccione A., Cataldi M., Secondo A., Castaldo P., Di Renzo G. and Taglialatela M. (2002) Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging? Neurobiol. Aging 23, 819-834.
5. Bai G. and Weiss B. (1991) The increase of calmodulin in PC12 cells induced by NGF is caused by differential expression of multiple mRNAs for calmodulin. J. Cell. Physiol. 149, 414-421.
6. Barger S. W. and Mattson M. P. (1996) Induction of neuroprotective kB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Brain Res. Mol. Brain Res. 40, 116-126.
7. Behl C. and Moosmann B. (2002) Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic. Biol. Med. 33, 182-191.
8. Behl C., Davis J., Cole G. M. and Schubert D. (1992) Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-950.
9. + efflux in the activation of apoptosis. J. Biol. Chem. 212, 32 436-32 442.
10. Castillo C., Carreno F., Villegas G. M. and Villegas R. (2001) Ionic currents in PC12 cells differentiated into neuron-like cells by a cultured-sciatic nerve conditioned medium. Brain Res. 911, 181-192.
11. + channels in rat microglia. Neurosci. Lett. 300, 67-70.
12. Colom L. V., Diaz M. E., Beers D. R., Neely A., Xie W. J. and Appel S. H. (1998) Role of potassium channels in amyloid-induced cell death. J. Neurochem. 70, 1925-1934.
13. Cone C. D. and Cone C. M. (1976) Induction of mitosis in mature neurons in central nervous system by sustained depolarization. Science 192, 155-158.
14. + channel in rat PC12 cells by hypoxia. J. Physiol. 502, 293-305.
15. 2-sensing and hypoxia tolerance in pheochromocytoma cells. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 128, 187-204.
16. Das K. P., Freudenrich T. M. and Mundy W. R. (2004) Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol. Teratol. 26, 397-406.
17. Diochot S., Schweitz H., Beress L. and Lazdunski M. (1998) Sea anemone peptides with a specific blocking activity against the fast inactivating potassium channel Kv3.4. J. Biol. Chem. 273, 6744-6749.
18. Etcheberrigaray R. and Bhagavan S. (1999) Ionic and signal transduction alterations in Alzheimer's disease: relevance of studies on peripheral cells. Mol. Neurobiol. 20, 93-109.
19. Ferrer I., Marti E., Lopez E. and Tortosa A. (1998) NF-kB immunoreactivity is observed in association with βA4 diffuse plaques in patients with Alzheimer's disease. Neuropathol. Appl. Neurobiol. 24, 271-277.
20. Fraser S. P., Suh Y. H. and Djamgoz M. B. (1997) Ionic effects of the Alzheimer's disease beta-amyloid precursor protein and its metabolic fragments. Trends Neurosci. 20, 67-72.
21. Furukawa K. and Mattson M. P. (1998) The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J. Neurochem. 70, 1876-1886.
22. + and cell shrinkage. A role for PKC upstream of caspases. J. Biol. Chem. 275, 19 609-19 619.
23. + current in rat hippocampal neurons. Biophys. J. 70, 296-304.
24. 2+ currents: involvement of ROS and NF-kB. J. Neurochem. 81, 1043-1051.
25. Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA 73, 2424-2428.
26. + channels in pheochromocytoma cells. J. Gen. Physiol. 91, 107-131.
27. Iwatsubo T, Odaka A., Suzuki N., Mizusawa H., Nukina N. and Ihara Y. (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13, 45-53.
28. - channel activity in rat cortical astrocytes. Brain Res. 746, 85-97.
29. Jhamandas J. H., Cho C., Jassar B., Harris K., MacTavish D. and Easaw J. (2001) Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons. J. Neurophysiol. 86, 1312-1320.
30. Koulich E., Nguyen T., Johnson K., Giardina C. and D'mello S. (2001) NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBbeta. J. Neurochem. 76, 1188-1198.
31. + channels. J. Biol. Chem. 278, 32 068-32 076.
32. Levee M. G., Dabrowska M. I., Lelli J. L. and Hinshaw D. B. (1996) Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am. J. Physiol. 271, 1981-1992.
33. Lin Y. Z., Yao S. Y., Veach R. A., Torgerson T. R. and Hawiger J. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14 255-14 258.
34. + release and cellular efflux in ischemic and apoptotic neuronal death. J. Neurochem. 86, 966-979.
35. + channel polypeptides in rat hippocampal neurons developing in situ and in vitro. J. Neurosci. 15, 3840-3851.
36. Mattson M. P. and Camandola S. (2001) NF-kB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247-254.
37. Mattson M. P. and Goodman Y. (1995) Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 676, 219-224.
38. McCrossan Z. A., Lewis A., Panaghie G., Jordan P. N., Christini D. J., Lemer D. J. and Abbott G. W. (2003) MinK-related peptide 2 modulates Kv2.1 and Kv3.1 potassium channels in mammalian brain. J. Neurosci. 23, 8077-8091.
39. McLaughlin B., Pal S., Tran M. P., Parsons A. A., Barone F. C., Erhardt J. A. and Aizenman E. (2001) p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis. J. Neurosci. 21, 3303-3311.
40. Michiels C., Minet E., Mottet D. and Raes M. (2002) Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic. Biol. Med. 33, 1231-1242.
41. + current in rat hippocampal neurons. J. Neurosci. 19, 1728-1735.
42. Nadeau H., McKinney S., Anderson D. J. and Lester H. A. (2000) ROMK1 (Kir1.1) causes apoptosis and chronic silencing of hippocampal neurons. J. Neurophysiol. 84, 1062-1075.
43. Panet H., Barzilai A., Daily D., Melamed E. and Offen D. (2001) Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells. J. Neurochem. 77, 391-398.
44. Perney T. M., Marshall J., Martin K. A., Hockfield S. and Kaczmarek L. K. (1992) Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain. J. Neurophysiol. 68, 756-766.
45. Pike C. J., Balazs R. and Cotman C. W. (1996) Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization. J. Neurochem. 67, 1774-1777.
46. + channel currents in primary cultures of rat cerebellar granule and cortical neurones. J. Neurochem. 79, 699-712.
47. Rettig J., Wunder F., Stocker M., Lichtinghagen R., Mastiaux F., Beckh S., Kues W., Pedarzani P., Schroter K. H. and Ruppersberg J. P. (1992) Characterization of a Shaw-related potassium channel family in rat brain. EMBO J. 11, 2473-2486.
48. + channels altered by presence of beta-subunit. Nature 369, 289-294.
49. + currents in rat hippocampal granule cells. J. Physiol. 537, 391-406.
50. Scorziello A., Pellegrini C., Forte L., Tortiglione A., Gioielli A., Iossa S., Amoroso S., Tufano R., Di Renzo G. and Annunziato L. (2001) Differential vulnerability of cortical and cerebellar neurons in primary culture to oxygen glucose deprivation followed by reoxygenation. J. Neurosci. Res. 63, 20-26.
51. 2+ oscillations in pituitary GH(3) cells. Mol. Pharmacol. 58, 1115-1128.
52. Seconde A., Sirabella R., Formisano L., D'Alessio A., Castaldo P., Amoroso S., Ingleton P., Di Renzo G. and Annunziato L. (2003) Involvement of PI3′-K, mitogen-activated protein kinase and protein kinase B in the up-regulation of the expression of nNOS-alpha and nNOSbeta splicing variants induced by PRL-receptor activation in GH3 cells. J. Neurochem. 84, 1367-1377.
53. Suh Y. H. and Checler F. (2002) Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol. Rev. 54, 469-525.
54. + channels by reactive oxygen species. Proc. Natl Acad. Sci. USA 94, 11 698-11 703.
55. 1 receptor blocker cetirizine as compared to other second-generation antihistamines. Mol. Pharmacol. 54, 113-121.
56. 2+ channels: a possible involvement of free radicals. J. Neurochem. 68, 265-271.
57. + channel. Proc. R. Soc. Lond. B Biol. Sci. 248, 9-18.
58. + current reveals microglial activation induced by HIV-1 Tat protein. Glia 33, 181-190.
59. Wu A., Derrico C. A., Hatem L. and Colvin R. A. (1997) Alzheimer's amyloid-beta peptide inhibits sodium/calcium exchange measured in rat and human brain plasma membrane vesicles. Neuroscience 80, 675-684.
60. Wu R. L., Butler M. D. and Barish M. E. (1998) Potassium current development and its linkage to membrane expansion during growth of cultured embryonic mouse hippocampal neurons: sensitivity to inhibitors of phosphatidylinositol 3-kinase and other protein kinases. J. Neurosci. 18, 6261-6278.
61. Yankner B. A., Duffy L. K. and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
62. Yu S. P. (2003) Regulation and critical role of potassium homeostasis in apoptosis. Prog. Neurobiol. 70, 363-386.
63. Yu S. P., Yeh C. H., Sensi S. L., Gwag B. J., Canzoniero L. M., Farhangrazi Z. S., Ying H. S., Tian M., Dugan L. L. and Choi D. W (1997) Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 278, 114-117.
64. + current in ceramide-induced caspase activation and apoptosis in cultured cortical neurons. J. Neurochem. 73, 933-941.
65. + efflux and neuronal apoptosis. Science 284, 336-339.